Loading icon
Research

EBSCO Research

Current News

Study protocol of a randomised, double-blind, placebo-controlled, two-arm parallel-group, multi-centre phase 3 pivotal trial to investigate the efficacy and safety of recombinant human alkaline phosphatase for treatment of patients with sepsis-associat...

Study protocol of a randomised, double-blind, placebo-controlled, two-arm parallel-group, multi-centre phase 3 pivotal trial to investigate the efficacy and safety of recombinant human alkaline phosphatase for treatment of patients with sepsis-associat... 2023-04-03 04:00:00

The synergistic effect of Cu-MOF nanoparticles and immunomodulatory agent on SARS-CoV-2 inhibition

The synergistic effect of Cu-MOF nanoparticles and immunomodulatory agent on SARS-CoV-2 inhibition 2023-04-03 04:00:00

Vulnerabilities and risk perceptions of contracting COVID-19 among Nepali migrant workers

Vulnerabilities and risk perceptions of contracting COVID-19 among Nepali migrant workers 2023-04-03 04:00:00

Arabic language version of the obsession with COVID-19 scale adaptation and validity evaluation in Saudi sample

Arabic language version of the obsession with COVID-19 scale adaptation and validity evaluation in Saudi sample 2023-04-03 04:00:00

Exploring the Potential of Broadly Neutralizing Antibodies for Treating SARS-CoV-2 Variants of Global Concern in 2023: A Comprehensive Clinical Review

Exploring the Potential of Broadly Neutralizing Antibodies for Treating SARS-CoV-2 Variants of Global Concern in 2023: A Comprehensive Clinical Review 2023-04-03 04:00:00

PICO Search Aid